|
1
|
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
|
Arthritis Rheum
|
2005
|
4.12
|
|
2
|
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2013
|
3.83
|
|
3
|
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
|
Arthritis Rheum
|
2006
|
3.51
|
|
4
|
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study.
|
Ann Rheum Dis
|
2013
|
3.43
|
|
5
|
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.
|
Rheumatol Int
|
2002
|
2.95
|
|
6
|
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
|
Arthritis Rheum
|
2008
|
2.75
|
|
7
|
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.
|
Arthritis Rheum
|
2006
|
2.67
|
|
8
|
Non-invasive measurement of brain viscoelasticity using magnetic resonance elastography.
|
NMR Biomed
|
2008
|
2.66
|
|
9
|
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
|
Ann Rheum Dis
|
2011
|
2.61
|
|
10
|
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.
|
Arthritis Rheumatol
|
2014
|
2.52
|
|
11
|
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.
|
Arthritis Rheum
|
2008
|
2.48
|
|
12
|
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
|
Arthritis Rheum
|
2009
|
2.45
|
|
13
|
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.
|
Ann Rheum Dis
|
2010
|
2.34
|
|
14
|
The impact of aging and gender on brain viscoelasticity.
|
Neuroimage
|
2009
|
2.15
|
|
15
|
The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns.
|
Arthritis Rheumatol
|
2014
|
2.14
|
|
16
|
Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes.
|
Arthritis Rheum
|
2008
|
2.14
|
|
17
|
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
|
Ann Rheum Dis
|
2012
|
2.10
|
|
18
|
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial.
|
Ann Rheum Dis
|
2013
|
2.08
|
|
19
|
Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity.
|
Phys Med Biol
|
2007
|
2.08
|
|
20
|
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two.
|
Arthritis Rheum
|
2008
|
2.04
|
|
21
|
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
1.90
|
|
22
|
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
|
N Engl J Med
|
2015
|
1.83
|
|
23
|
MR-elastography reveals degradation of tissue integrity in multiple sclerosis.
|
Neuroimage
|
2009
|
1.83
|
|
24
|
Assessment of liver viscoelasticity using multifrequency MR elastography.
|
Magn Reson Med
|
2008
|
1.80
|
|
25
|
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
|
Arthritis Rheum
|
2003
|
1.79
|
|
26
|
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.
|
Ann Rheum Dis
|
2013
|
1.74
|
|
27
|
In vivo viscoelastic properties of the brain in normal pressure hydrocephalus.
|
NMR Biomed
|
2010
|
1.67
|
|
28
|
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
|
Arthritis Rheum
|
2012
|
1.66
|
|
29
|
Concepts and epidemiology of spondyloarthritis.
|
Best Pract Res Clin Rheumatol
|
2006
|
1.57
|
|
30
|
Fractional encoding of harmonic motions in MR elastography.
|
Magn Reson Med
|
2007
|
1.49
|
|
31
|
MR elastography of the human heart: noninvasive assessment of myocardial elasticity changes by shear wave amplitude variations.
|
Magn Reson Med
|
2009
|
1.47
|
|
32
|
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2010
|
1.43
|
|
33
|
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis.
|
PLoS One
|
2012
|
1.41
|
|
34
|
Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES.
|
Magn Reson Med
|
2004
|
1.41
|
|
35
|
In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography.
|
Invest Radiol
|
2006
|
1.35
|
|
36
|
Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.
|
J Rheumatol
|
2006
|
1.35
|
|
37
|
Predicting the outcome of ankylosing spondylitis therapy.
|
Ann Rheum Dis
|
2011
|
1.35
|
|
38
|
Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
|
Arthritis Care Res (Hoboken)
|
2012
|
1.34
|
|
39
|
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.
|
Ann Rheum Dis
|
2011
|
1.33
|
|
40
|
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group.
|
Ann Rheum Dis
|
2012
|
1.30
|
|
41
|
Shear wave group velocity inversion in MR elastography of human skeletal muscle.
|
Magn Reson Med
|
2006
|
1.29
|
|
42
|
Viscoelasticity-based MR elastography of skeletal muscle.
|
Phys Med Biol
|
2010
|
1.29
|
|
43
|
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2013
|
1.29
|
|
44
|
ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.
|
Arthritis Rheum
|
2005
|
1.28
|
|
45
|
In vivo waveguide elastography of white matter tracts in the human brain.
|
Magn Reson Med
|
2012
|
1.23
|
|
46
|
Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.
|
J Rheumatol
|
2002
|
1.21
|
|
47
|
Alteration of brain viscoelasticity after shunt treatment in normal pressure hydrocephalus.
|
Neuroradiology
|
2011
|
1.21
|
|
48
|
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial.
|
Ann Rheum Dis
|
2010
|
1.20
|
|
49
|
First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.
|
Rheumatology (Oxford)
|
2012
|
1.19
|
|
50
|
Cardiac magnetic resonance elastography. Initial results.
|
Invest Radiol
|
2008
|
1.17
|
|
51
|
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.
|
Arthritis Rheum
|
2006
|
1.15
|
|
52
|
Cardiac MR elastography: comparison with left ventricular pressure measurement.
|
J Cardiovasc Magn Reson
|
2009
|
1.13
|
|
53
|
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
|
Neuroimage Clin
|
2012
|
1.11
|
|
54
|
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty.
|
FASEB J
|
2004
|
1.10
|
|
55
|
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
|
J Rheumatol
|
2007
|
1.08
|
|
56
|
The influence of physiological aging and atrophy on brain viscoelastic properties in humans.
|
PLoS One
|
2011
|
1.08
|
|
57
|
Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.
|
Arthritis Rheum
|
2002
|
1.07
|
|
58
|
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
|
Arthritis Rheum
|
2006
|
1.07
|
|
59
|
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
|
Ann Rheum Dis
|
2013
|
1.05
|
|
60
|
Viscoelastic properties of liver measured by oscillatory rheometry and multifrequency magnetic resonance elastography.
|
Biorheology
|
2010
|
1.05
|
|
61
|
Wide-range dynamic magnetic resonance elastography.
|
J Biomech
|
2011
|
1.04
|
|
62
|
Multifrequency inversion in magnetic resonance elastography.
|
Phys Med Biol
|
2012
|
1.04
|
|
63
|
Analysis of wave patterns in MR elastography of skeletal muscle using coupled harmonic oscillator simulations.
|
Magn Reson Imaging
|
2002
|
1.02
|
|
64
|
MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.
|
Ann Rheum Dis
|
2012
|
1.00
|
|
65
|
In vivo magnetic resonance elastography of human brain at 7 T and 1.5 T.
|
J Magn Reson Imaging
|
2010
|
0.98
|
|
66
|
Elasticity-based determination of isovolumetric phases in the human heart.
|
J Cardiovasc Magn Reson
|
2010
|
0.98
|
|
67
|
Shear-wave amplitudes measured with cardiac MR elastography for diagnosis of diastolic dysfunction.
|
Radiology
|
2014
|
0.96
|
|
68
|
Cardiac magnetic resonance elastography: toward the diagnosis of abnormal myocardial relaxation.
|
Invest Radiol
|
2010
|
0.96
|
|
69
|
Scatter-based magnetic resonance elastography.
|
Phys Med Biol
|
2009
|
0.93
|
|
70
|
A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis.
|
J Rheumatol
|
2006
|
0.93
|
|
71
|
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
|
J Rheumatol
|
2005
|
0.93
|
|
72
|
Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
|
J Rheumatol
|
2005
|
0.92
|
|
73
|
A stratified model for health outcomes in ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
0.92
|
|
74
|
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.
|
Arthritis Res Ther
|
2007
|
0.92
|
|
75
|
Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC).
|
Ann Rheum Dis
|
2013
|
0.91
|
|
76
|
In vivo measurement of volumetric strain in the human brain induced by arterial pulsation and harmonic waves.
|
Magn Reson Med
|
2012
|
0.91
|
|
77
|
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
|
Rheumatol Int
|
2013
|
0.91
|
|
78
|
Magnetic resonance elastography and diffusion-weighted imaging of the sol/gel phase transition in agarose.
|
J Magn Reson
|
2004
|
0.91
|
|
79
|
Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.
|
Rheumatology (Oxford)
|
2012
|
0.90
|
|
80
|
MR elastography in a murine stroke model reveals correlation of macroscopic viscoelastic properties of the brain with neuronal density.
|
NMR Biomed
|
2013
|
0.90
|
|
81
|
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis.
|
Open Rheumatol J
|
2010
|
0.90
|
|
82
|
Magnetic resonance imaging in ankylosing spondylitis.
|
Curr Opin Rheumatol
|
2007
|
0.89
|
|
83
|
Update on biologic therapy in the management of axial spondyloarthritis.
|
Curr Rheumatol Rep
|
2010
|
0.88
|
|
84
|
Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.
|
J Rheumatol
|
2008
|
0.88
|
|
85
|
Methotrexate: optimizing the efficacy in rheumatoid arthritis.
|
Ther Adv Musculoskelet Dis
|
2011
|
0.88
|
|
86
|
Application of nanoscale zero valent iron (NZVI) for groundwater remediation in Europe.
|
Environ Sci Pollut Res Int
|
2011
|
0.88
|
|
87
|
In vivo waveguide elastography: effects of neurodegeneration in patients with amyotrophic lateral sclerosis.
|
Magn Reson Med
|
2013
|
0.88
|
|
88
|
Opinion: Perspectives on imaging in axial spondyloarthritis.
|
Nat Rev Rheumatol
|
2013
|
0.87
|
|
89
|
Assessments in ankylosing spondylitis.
|
Best Pract Res Clin Rheumatol
|
2007
|
0.86
|
|
90
|
Two-dimensional waveform analysis in MR elastography of skeletal muscles.
|
Phys Med Biol
|
2005
|
0.86
|
|
91
|
Assessments in ankylosing spondylitis.
|
Best Pract Res Clin Rheumatol
|
2006
|
0.86
|
|
92
|
Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.
|
Rheumatology (Oxford)
|
2013
|
0.86
|
|
93
|
Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study.
|
Arthritis Care Res (Hoboken)
|
2012
|
0.86
|
|
94
|
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?
|
J Rheumatol
|
2007
|
0.85
|
|
95
|
Fractal network dimension and viscoelastic powerlaw behavior: I. A modeling approach based on a coarse-graining procedure combined with shear oscillatory rheometry.
|
Phys Med Biol
|
2012
|
0.85
|
|
96
|
Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.
|
Neuroimage Clin
|
2013
|
0.85
|
|
97
|
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE).
|
Rheumatology (Oxford)
|
2012
|
0.85
|
|
98
|
Systematic review of measures and their concepts used in published studies focusing on the treatment of acute inflammatory arthritis.
|
Clin Rheumatol
|
2006
|
0.85
|
|
99
|
Diffusion- and perfusion-weighted MR imaging in a patient with acute demyelinating encephalomyelitis (ADEM).
|
J Magn Reson Imaging
|
2002
|
0.84
|
|
100
|
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.
|
Clin Rheumatol
|
2006
|
0.84
|
|
101
|
Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial.
|
Arthritis Care Res (Hoboken)
|
2010
|
0.84
|
|
102
|
In vivo high-resolution magnetic resonance elastography of the uterine corpus and cervix.
|
Eur Radiol
|
2014
|
0.84
|
|
103
|
Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
|
Rheumatology (Oxford)
|
2012
|
0.83
|
|
104
|
Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
|
J Rheumatol
|
2005
|
0.83
|
|
105
|
Expanding the armamentarium for the spondyloarthropathies.
|
Arthritis Res Ther
|
2004
|
0.83
|
|
106
|
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.
|
Ann Rheum Dis
|
2011
|
0.82
|
|
107
|
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
|
Expert Opin Biol Ther
|
2006
|
0.81
|
|
108
|
Vibration-synchronized magnetic resonance imaging for the detection of myocardial elasticity changes.
|
Magn Reson Med
|
2012
|
0.81
|
|
109
|
Phase preparation in steady-state free precession MR elastography.
|
Magn Reson Imaging
|
2007
|
0.81
|
|
110
|
One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare.
|
Ann Rheum Dis
|
2012
|
0.81
|
|
111
|
Adalimumab for the treatment of ankylosing spondylitis.
|
Expert Opin Pharmacother
|
2007
|
0.80
|
|
112
|
Towards compression-sensitive magnetic resonance elastography of the liver: sensitivity of harmonic volumetric strain to portal hypertension.
|
J Magn Reson Imaging
|
2013
|
0.80
|
|
113
|
Measurement of vibration-induced volumetric strain in the human lung.
|
Magn Reson Med
|
2012
|
0.80
|
|
114
|
Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis.
|
J Rheumatol
|
2013
|
0.80
|
|
115
|
Isovolumetric elasticity alteration in the human heart detected by in vivo time-harmonic elastography.
|
Ultrasound Med Biol
|
2013
|
0.80
|
|
116
|
Imaging in axial spondyloarthritis: diagnostic problems and pitfalls.
|
Rheum Dis Clin North Am
|
2012
|
0.79
|
|
117
|
An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.
|
Clin Rheumatol
|
2004
|
0.79
|
|
118
|
Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations.
|
Rheumatol Int
|
2007
|
0.79
|
|
119
|
The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.
|
Clin Rheumatol
|
2005
|
0.78
|
|
120
|
In vivo abdominal magnetic resonance elastography for the assessment of portal hypertension before and after transjugular intrahepatic portosystemic shunt implantation.
|
Invest Radiol
|
2015
|
0.78
|
|
121
|
In Vivo time harmonic elastography of the human heart.
|
Ultrasound Med Biol
|
2011
|
0.78
|
|
122
|
Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis.
|
Expert Opin Pharmacother
|
2006
|
0.78
|
|
123
|
Response to 'Evidence in Support of the Validity of the TNF Brake Hypothesis' by Maksymowych.
|
Ann Rheum Dis
|
2013
|
0.78
|
|
124
|
Multifrequency Magnetic Resonance Elastography for the Assessment of Renal Allograft Function.
|
Invest Radiol
|
2016
|
0.77
|
|
125
|
Withdrawal of biologic therapy in axial spondyloarthritis: the experience in established disease.
|
Clin Exp Rheumatol
|
2013
|
0.77
|
|
126
|
Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratios.
|
BMC Cardiovasc Disord
|
2007
|
0.77
|
|
127
|
Anti-TNF agents for the treatment of spondyloarthropathies.
|
Expert Opin Emerg Drugs
|
2002
|
0.77
|
|
128
|
Alterations of the proton-T2 time in relaxed skeletal muscle induced by passive extremity flexions.
|
J Magn Reson Imaging
|
2006
|
0.77
|
|
129
|
Time-Resolved Analysis of Left Ventricular Shear Wave Amplitudes in Cardiac Elastography for the Diagnosis of Diastolic Dysfunction.
|
Invest Radiol
|
2016
|
0.76
|
|
130
|
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials.
|
Int J Technol Assess Health Care
|
2007
|
0.76
|
|
131
|
How important is early therapy in axial spondyloarthritis?
|
Rheum Dis Clin North Am
|
2012
|
0.76
|
|
132
|
In vivo time-harmonic multifrequency elastography of the human liver.
|
Phys Med Biol
|
2014
|
0.76
|
|
133
|
Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.76
|
|
134
|
Infection and work stress are potential triggers of ankylosing spondylitis.
|
Clin Rheumatol
|
2006
|
0.76
|
|
135
|
Management and treatment of ankylosing spondylitis.
|
Curr Opin Rheumatol
|
2005
|
0.75
|
|
136
|
The risks of smoking in patients with spondyloarthritides.
|
Ann Rheum Dis
|
2012
|
0.75
|
|
137
|
Synovitis in spondyloarthritides.
|
Open Rheumatol J
|
2011
|
0.75
|
|
138
|
Spondyloarthropathies: the disease process in axial SpA: what can biomarkers tell us?
|
Nat Rev Rheumatol
|
2011
|
0.75
|
|
139
|
Prevalence of spondyloarthropathy in Japan.
|
J Rheumatol
|
2002
|
0.75
|
|
140
|
The Structured Delegation of Medical Care Services for Patients With Inflammatory Rheumatic Diseases-Findings of a Randomized Controlled Trial (the StärkeR Project).
|
Dtsch Arztebl Int
|
2022
|
0.75
|
|
141
|
An empirical model to predict the distribution of iron micro-particles around an injection well in a sandy aquifer.
|
J Contam Hydrol
|
2012
|
0.75
|
|
142
|
[Comments by the German Society of Rheumatology (DGRh) to report on the plan for Biologicals in the second-line therapy of rheumatoid arthritis].
|
Z Rheumatol
|
2011
|
0.75
|
|
143
|
Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype.
|
Ann Rheum Dis
|
2013
|
0.75
|
|
144
|
[The initial results of the Metex Study].
|
Krankenpfl J
|
2005
|
0.75
|
|
145
|
Response to: 'Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRA main and extension studies: utility of laboratory methods description' by Francesca Meacci et al.
|
Ann Rheum Dis
|
2016
|
0.75
|
|
146
|
Magnetic resonance imaging in spondyloarthropathies.
|
Joint Bone Spine
|
2005
|
0.75
|
|
147
|
Quantifying bone marrow edema in the rheumatoid cervical spine using magnetic resonance imaging.
|
J Rheumatol
|
2010
|
0.75
|
|
148
|
In Reply.
|
Dtsch Arztebl Int
|
2017
|
0.75
|
|
149
|
Wegener's granulomatosis presenting as necrosis of the left mainstem bronchus.
|
Asian Cardiovasc Thorac Ann
|
2002
|
0.75
|
|
150
|
[Gratitude].
|
Med Klin (Munich)
|
2005
|
0.75
|
|
151
|
The risks of smoking in patients with spondyloarthritides.
|
Postgrad Med J
|
2012
|
0.75
|
|
152
|
Withdrawal of medical therapies in axial spondyloarthritis: what would be the optimal trial design?
|
Clin Exp Rheumatol
|
2013
|
0.75
|
|
153
|
Remission of a CNS inflammatory disease accompanied by newly developed ANA and arthropathy during treatment with IFN-beta.
|
J Neurol
|
2002
|
0.75
|
|
154
|
A new physical model based on cascading column experiments to reproduce the radial flow and transport of micro-iron particles.
|
J Contam Hydrol
|
2012
|
0.75
|
|
155
|
Liquid-Liver Phantom: Mimicking the Viscoelastic Dispersion of Human Liver for Ultrasound- and MRI-Based Elastography.
|
Invest Radiol
|
2022
|
0.75
|
|
156
|
Inflammatory back pain.
|
Rheum Dis Clin North Am
|
2012
|
0.75
|
|
157
|
Modeling ground water flow in alluvial mountainous catchments on a watershed scale.
|
Ground Water
|
2008
|
0.75
|